China State Construction International Holdings Ltd (CSCI) is a provider of construction and related investment activities. It operates in various sectors, including building construction, civil engineering, foundation engineering, mechanical and electrical engineering, and investment-driven contracting. The company serves markets in China, Hong Kong, and Macau, focusing on infrastructure assets, prefabricated construction, and other construction-related businesses.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

CSCI remains committed to technology-empowered development, continuously strengthening its R&D and innovation capabilities. CSC Hailong, a leading enterprise in Modular Integrated Construction (MiC) under the company's subsidiary structure, has successfully implemented key national R&D projects and co-organised the Technical Exchange Conference on Modular Integrated Construction. The company also initiated the establishment of the Guangdong-Hong Kong-Macao Modular Integrated Construction Industry Alliance to integrate resources and promote collaboration among industries in the region. Additionally, CCE Macau secured a joint research funding project for 2025 supported by the Macao Science and Technology Development Fund and the National Natural Science Foundation of China. The company's technological products were showcased at high-profile exhibitions, earning wide acclaim and enhancing its profile. The company received numerous major science and technology awards, demonstrating strong capabilities in scientific and technological innovation. In FY2025, the company invested CNY818 million in R&D, with the proportion of R&D investment to revenue reaching 0.8%.